Celltrion, Teva announce FDA approval of HERZUMA

BioTech |  News | 0 Comment | 18 Dec, 2018

Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. have announced that the U.S. Food and Drug Administration (FDA) has approved HERZUMA [®] (trastuzumab-pkrb), a HER2/neu receptor ...Read more

NeuClone discloses its sixth biosimilar candidate of Pertuzumab

BioTech |  News | 0 Comment | 18 Dec, 2018

NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products has disclosed the sixth biosimilar be...Read more

KORIL approves Cellect's grant application for stem cells therapy

BioTech |  News | 1 Comment | 18 Dec, 2018

Cellect Biotechnology Ltd., a developer of a novel stem cell production technology, announced that KORIL-RDF, has approved Cellect's grant application, submitted with Cell2in, a Korean cell...Read more

bioLIVE China 2019 to lead Bio-Pharma technology in Asia

BioTech |  News | 0 Comment | 17 Dec, 2018

The bio-pharma display platform with 7 years of experience in China, BioPh China, will be newly upgraded to bioLIVE China from June 18-20, ...Read more

Generex receives IND approval from FDA

BioTech |  News | 0 Comment | 14 Dec, 2018

Generex Biotechnology Corporation has announced that the FDA had reviewed the company’s investigational new drug (IND) application and given notification that the study can proceed. T...Read more

Cathay Biotech expands production capacity for new Bio-based materials

BioTech |  News | 2 Comment | 13 Dec, 2018

The government of the city of Wusu (Xinjiang, China) and Cathay Industrial Biotech Co., Ltd. ("Cathay") signed an agreement for the expansion of Cathay's production in Wusu. Cathay has...Read more

GHIT Fund to invest $4.6M for new projects on drug development

BioTech |  News | 0 Comment | 13 Dec, 2018

The Global Health Innovative Technology (GHIT) Fund has announced a total of 520 million yen ($4.6 million) to support four partnerships to develop new lifesaving drugs and vaccines for mal...Read more

Roche, Merck partner to develop a companion diagnostic test

BioTech |  News | 0 Comment | 12 Dec, 2018

Roche has announced that it entered into a collaboration with Merck (known as MSD outside the United States and Canada) to develop a companion diagnostic test to identify patients eligible ...Read more

HiFiBio develops JV for immune-oncology research

BioTech |  News | 0 Comment | 12 Dec, 2018

HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, has announced the formation of Victa Biotherapeutics, a joint ven...Read more

GenEdit Closes $8.5M Series Seed Financing

BioTech |  News | 0 Comment | 11 Dec, 2018

US based company GenEdit has announced the completion of a $8.5 million Series Seed financing round led by new investors Data Collective Bio (DCVC Bio) and SK Holdings. This roun...Read more

Brii Biosciences builds innovative pipeline

BioTech |  News | 0 Comment | 10 Dec, 2018

Brii Biosciences, a company committed to serving patients’ needs and improving public health in China, has announced several research collaborations that significantly advance its eff...Read more

Shuwen Biotech wins outstanding award in China Innovation, Entrepreneurship Competition

BioTech |  News | 0 Comment | 07 Dec, 2018

Shuwen Biotech announces its winning of an outstanding award in the national finals for the 7th Annual Innovation and Entrepreneurship organized by Chinese Ministry of Science and Tech...Read more

Impel NeuroPharma Closes $67.5M Series D Financing

BioTech |  News | 0 Comment | 07 Dec, 2018

Seattle-based biotechnology company, Impel NeuroPharma has announced that it has completed a Series D financing totaling $67,500,000. The investment is co-led by KKR and Norwest Venture Pa...Read more

Revance Therapeutics enters into agreement with Fosun Pharma

BioTech |  News | 0 Comment | 06 Dec, 2018

Revance Therapeutics, Inc. a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions has announced that the company has ent...Read more

Phagomed wins Austrian entrepreneurship award

BioTech |  News | 0 Comment | 05 Dec, 2018

Vienna-based Biotech Company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phönix 2018 in the category “Start-Up International”. The Pho...Read more

AUM Biosciences acquires novel anti-cancer drug

BioTech |  News | 0 Comment | 04 Dec, 2018

AUM Biosciences (AUM), a Singapore headquartered oncology-focused biotechnology company, has licensed its first novel, highly selective anti-cancer drug, ETC-206 , from A*STAR's Experimenta...Read more

Editas Medicine announces pre-clinical data for treatment of Sickle Cell Diseases

BioTech |  News | 0 Comment | 03 Dec, 2018

Editas Medicine, a genome editing company has announced results from experiments to demonstrate expanded CRISPR genome editing strategies in hematopoietic stem cells for the treatment of si...Read more

FDA approves first treatment developed by Catalyst Pharma for LEMS

BioTech |  News | 0 Comment | 01 Dec, 2018

The U.S. Food and Drug Administration has approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disord...Read more